Paradigm Biocapital Advisors LP
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
36
- Value ($000)
$3,516,197
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001855655
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NUVL NUVALENT INC | COM | 670703107 | $455.70 M | 13 % | 5,269,433 | ||
MERUS N V | COM | N5749R100 | $411.79 M | 12 % | 4,373,770 | ||
ACLX ARCELLX INC | COMMON STOCK | 03940C100 | $381.68 M | 11 % | 4,649,016 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $290.63 M | 8 % | 6,223,291 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $158.42 M | 5 % | 2,665,698 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $136.33 M | 4 % | 3,784,755 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $132.80 M | 4 % | 1,564,196 | ||
GMAB GENMAB A/S | SPONSORED ADS | 372303206 | $117.06 M | 3 % | 3,816,851 | ||
AGIO AGIOS PHARMACEUTICALS INC | COM | 00847X104 | $107.32 M | 3 % | 2,673,555 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $106.24 M | 3 % | 2,550,774 |
Rows Per Page
10
- 10
- 50
- 100